Chuangxing Guo

Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth

Brion W. Murray, Chuangxing Guo, Joseph Piraino et al. · Proceedings of the National Academy of Sciences · 2010 · 321 citations · Full text

Medicine, Oncology, Pharmacology +15

Interphylal Product Splicing:  The First Total Syntheses of Cephalostatin 1, the North Hemisphere of Ritterazine G, and the Highly Active Hybrid Analogue, Ritterostatin G_N1_N¹

Thomas Lacour, Chuangxing Guo, Sudhakar Bhandaru et al. · Journal of the American Chemical Society · 1998 · 110 citations

Medicine, Medicinal Chemistry, Pharmacology +6

Structure-based design of novel human Pin1 inhibitors (I)

Chuangxing Guo, Xinjun Hou, Liming Dong et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 106 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Structure-based design of novel human Pin1 inhibitors (II)

Liming Dong, Joseph Marakovits, Xinjun Hou et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 86 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Systematic Structure Modifications of Imidazo[1,2-<i>a</i>]pyrimidine to Reduce Metabolism Mediated by Aldehyde Oxidase (AO)

Angelica Linton, Ping Kang, Martha A. Ornelas et al. · Journal of Medicinal Chemistry · 2011 · 81 citations

Medicine, Medicinal Chemistry, Pharmacology +16